Form 4: Daxor Corp CEO Michael Feldschuh Acquires Additional Shares
SEC Form 4 Filing
Daxor Corp's CEO, Michael Richard Feldschuh, purchased 2,063 shares of the company's common stock at $7.89 per share on April 4, 2025.
Summary
- On April 4, 2025, Michael Richard Feldschuh, the CEO of Daxor Corp, acquired 2,063 shares of Daxor Common Stock.
- The purchase price was $7.89 per share.
- Following the transaction, Feldschuh directly owns 212,694 shares of Daxor Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally seen as a positive sign, but without additional context, it's difficult to gauge the overall impact.
Positives
- The CEO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider trading activity is closely monitored by investors as it can provide insights into management's perspective on the company's valuation and future performance.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive signal, potentially increasing investor confidence.
Key Dates
| Date | Description |
|---|---|
| 04/04/2025 | Date of transaction: Michael Feldschuh purchased 2,063 shares of Daxor Common Stock. |
| 04/07/2025 | Date of signature on the Form 4 filing. |
Keywords
Daxor Corp, Michael Feldschuh, insider trading, stock purchase, Form 4, beneficial ownership, DXR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.